These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 12410186

  • 1. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R, Jakubowicz S.
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [Abstract] [Full Text] [Related]

  • 2. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Nov; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 3. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 5. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
    Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL.
    Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
    [Abstract] [Full Text] [Related]

  • 6. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E, Cassorla F, Tiulpakov AN, Mericq MV, Avila A, Pescovitz OH, Svensson J, Cerchio K, Krupa D, Gertz BJ, Murphy G.
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 8. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 9. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.
    Marchisotti FG, Jorge AA, Montenegro LR, Berger K, de Carvalho LR, Mendonca BB, Arnhold IJ.
    Growth Horm IGF Res; 2009 Apr 03; 19(2):179-86. PubMed ID: 19036620
    [Abstract] [Full Text] [Related]

  • 10. Effect of nutrition on growth in short stature before and during growth-hormone therapy.
    Zadik Z, Sinai T, Zung A, Reifen R.
    Pediatrics; 2005 Jul 03; 116(1):68-72. PubMed ID: 15995033
    [Abstract] [Full Text] [Related]

  • 11. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Jul 03; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 12. Effects of the IGF-I/IGFBP-3 complex on GH and ghrelin nocturnal concentrations in low birth weight children.
    Iñiguez G, Salazar T, Roman R, Avila A, Gunn RD, Cassorla F.
    Clin Endocrinol (Oxf); 2006 Nov 03; 65(5):687-92. PubMed ID: 17054474
    [Abstract] [Full Text] [Related]

  • 13. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA, Postlethwaite RJ, Price DA, Clayton PE.
    Pediatr Nephrol; 2002 Aug 03; 17(8):643-7. PubMed ID: 12185474
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 03; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 15. The usefulness of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for evaluation of children with short stature.
    Jaruratanasirikul S, Leethanaporn K, Sriplung H.
    J Med Assoc Thai; 2000 Jun 03; 83(6):619-26. PubMed ID: 10932487
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan 03; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 17. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 03; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 18. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec 03; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 19. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G, Izzo G, La Montagna G, Bellastella A.
    Clin Endocrinol (Oxf); 1996 Jul 03; 45(1):27-32. PubMed ID: 8796135
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK, Price DA, Gill MS, Whatmore AJ, Addison GM, Clayton PE.
    Pediatr Res; 1996 May 03; 39(5):849-55. PubMed ID: 8726240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.